HK Stock MarketDetailed Quotes

06185 CANSINOBIO

Watchlist
  • 16.500
  • -1.220-6.88%
Market Closed Apr 19 16:08 CST
4.08BMarket Cap-2495P/E (TTM)

CANSINOBIO Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
Turnover
-66.52%345.18M
-75.17%175.63M
-96.65%21.09M
-79.86%100.55M
-76.02%1.03B
-77.08%707.4M
-69.45%629.79M
6.98%499.36M
23,086.49%4.3B
54,286.51%3.09B
Operating income
-66.52%345.18M
-75.17%175.63M
-96.65%21.09M
-79.86%100.55M
-76.02%1.03B
-77.08%707.4M
-69.45%629.79M
6.98%499.36M
23,086.49%4.3B
54,286.51%3.09B
Cost of sales
-0.29%-1.22B
----
-154.31%-797.57M
----
6.17%-1.22B
----
49.85%-313.62M
----
-9,301.40%-1.3B
----
Operating expenses
-0.29%-1.22B
28.54%-172.72M
-154.31%-797.57M
56.10%-65.19M
6.17%-1.22B
76.91%-241.69M
49.85%-313.62M
33.73%-148.47M
-9,301.40%-1.3B
-207,805.96%-1.05B
Gross profit
-369.45%-876.02M
-99.37%2.91M
-345.59%-776.49M
-89.92%35.37M
-106.22%-186.61M
-77.16%465.71M
-77.98%316.17M
44.57%350.88M
63,231.92%3B
39,339.44%2.04B
Selling expenses
-32.55%-353.4M
-29.84%-193.63M
-44.93%-128.84M
-60.25%-54.98M
-151.95%-266.61M
-132.61%-149.14M
-157.07%-88.9M
-378.52%-34.31M
-538.92%-105.82M
-689.03%-64.11M
Administrative expenses
-5.89%-294.45M
11.11%-188.09M
-0.30%-140.05M
5.54%-60.55M
-19.95%-278.07M
-49.97%-211.61M
-54.35%-139.63M
-330.93%-64.1M
-179.71%-231.81M
-178.05%-141.11M
Research and development expenses
18.02%-637.99M
15.92%-461.67M
-4.45%-338.37M
4.70%-149.77M
11.43%-778.26M
16.27%-549.07M
41.23%-323.97M
41.75%-157.16M
-105.08%-878.72M
-271.09%-655.77M
Profit from asset sales
----
--37.46K
----
----
----
----
----
----
----
----
Revaluation surplus
----
-379.50%-15.37M
----
56.12%7.17M
----
-82.25%5.5M
----
670.43%4.59M
----
209.47%30.98M
-Changes in the fair value of other assets
----
-379.50%-15.37M
----
56.12%7.17M
----
-82.25%5.5M
----
670.43%4.59M
----
209.47%30.98M
Impairment and provision
-71.43%-15.05M
-50.46%-801.12M
-338.13%-20.26M
-108.88%-12.87M
-381.20%-8.78M
-11,281.90%-532.45M
-6,148.65%-4.62M
-76,937.50%-6.16M
-366.50%-1.82M
---4.68M
-Other impairment is provision
-71.43%-15.05M
-50.46%-801.12M
-338.13%-20.26M
-108.88%-12.87M
-381.20%-8.78M
-11,281.90%-532.45M
-6,148.65%-4.62M
-76,937.50%-6.16M
-366.50%-1.82M
---4.68M
Special items of operating profit
-5.26%141.72M
44.00%167.28M
-19.13%61.58M
31.82%51.03M
16.99%149.58M
204.12%116.16M
78.83%76.15M
499.30%38.72M
4.19%127.85M
13.35%38.2M
Operating profit
-48.69%-2.04B
-73.96%-1.5B
-714.58%-1.34B
-242.43%-186.54M
-171.60%-1.37B
-169.67%-859.78M
-120.54%-164.8M
391.65%130.97M
576.88%1.91B
751.39%1.23B
Financing income
-46.75%120.64M
----
-36.10%88.49M
----
184.45%226.57M
----
235.72%138.49M
----
151.10%79.65M
----
Financing cost
-53.82%-64.34M
-62.52%80.29M
-92.87%-29.4M
36.14%-5.81M
23.21%-41.83M
250.27%214.19M
-125.86%-15.24M
-131.68%-9.1M
-98.09%-54.48M
379.25%61.15M
Special items of earning before tax
----
-3,128.89%-40.7M
----
-729.32%-8.12M
----
74.07%-1.26M
----
-323.52%-979K
----
-703.60%-4.86M
Earning before tax
-67.14%-1.98B
-125.10%-1.46B
-2,988.28%-1.28B
-265.82%-200.47M
-161.13%-1.18B
-150.13%-646.85M
-104.97%-41.56M
867.49%120.9M
588.30%1.94B
833.63%1.29B
Tax
-94.78%11.45M
-99.26%1.16M
-97.98%1.16M
558.59%30.27M
838.17%219.24M
263.56%158.17M
-42.57%57.6M
---6.6M
---29.7M
--43.51M
After-tax profit from continuing operations
-103.93%-1.97B
-197.72%-1.45B
-8,092.09%-1.28B
-248.91%-170.2M
-150.59%-964.76M
-136.64%-488.68M
-98.29%16.04M
825.59%114.3M
580.81%1.91B
858.36%1.33B
Earning after tax
-103.93%-1.97B
-197.72%-1.45B
-8,092.09%-1.28B
-248.91%-170.2M
-150.59%-964.76M
-136.64%-488.68M
-98.29%16.04M
825.59%114.3M
580.81%1.91B
858.36%1.33B
Minority profit
-776.08%-484.7M
-3,192.65%-469.89M
-11,683.23%-440.74M
-330.63%-30.65M
-657.48%-55.33M
---14.27M
--3.81M
-334.55%-7.12M
---7.3M
----
Profit attributable to shareholders
-63.04%-1.48B
-107.63%-985.03M
-6,975.54%-841.43M
-214.94%-139.55M
-147.51%-909.43M
-135.57%-474.41M
-98.69%12.24M
960.23%121.41M
582.65%1.91B
858.36%1.33B
Basic earnings per share
-63.32%-6.01
-107.81%-3.99
-6,920.00%-3.41
-216.33%-0.57
-147.55%-3.68
-135.62%-1.92
-98.68%0.05
916.67%0.49
550.00%7.74
791.03%5.39
Diluted earnings per share
-63.32%-6.01
-107.81%-3.99
-6,920.00%-3.41
-216.33%-0.57
-147.55%-3.68
-135.62%-1.92
-98.68%0.05
916.67%0.49
550.00%7.74
791.03%5.39
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
CAS (2007)
HKAS
CAS (2007)
HKAS
CAS (2007)
HKAS
CAS (2007)
HKAS
CAS (2007)
Audit Opinions
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Auditor
Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership)
--
--
--
Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership)
--
--
--
Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership)
--
(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021
Turnover -66.52%345.18M-75.17%175.63M-96.65%21.09M-79.86%100.55M-76.02%1.03B-77.08%707.4M-69.45%629.79M6.98%499.36M23,086.49%4.3B54,286.51%3.09B
Operating income -66.52%345.18M-75.17%175.63M-96.65%21.09M-79.86%100.55M-76.02%1.03B-77.08%707.4M-69.45%629.79M6.98%499.36M23,086.49%4.3B54,286.51%3.09B
Cost of sales -0.29%-1.22B-----154.31%-797.57M----6.17%-1.22B----49.85%-313.62M-----9,301.40%-1.3B----
Operating expenses -0.29%-1.22B28.54%-172.72M-154.31%-797.57M56.10%-65.19M6.17%-1.22B76.91%-241.69M49.85%-313.62M33.73%-148.47M-9,301.40%-1.3B-207,805.96%-1.05B
Gross profit -369.45%-876.02M-99.37%2.91M-345.59%-776.49M-89.92%35.37M-106.22%-186.61M-77.16%465.71M-77.98%316.17M44.57%350.88M63,231.92%3B39,339.44%2.04B
Selling expenses -32.55%-353.4M-29.84%-193.63M-44.93%-128.84M-60.25%-54.98M-151.95%-266.61M-132.61%-149.14M-157.07%-88.9M-378.52%-34.31M-538.92%-105.82M-689.03%-64.11M
Administrative expenses -5.89%-294.45M11.11%-188.09M-0.30%-140.05M5.54%-60.55M-19.95%-278.07M-49.97%-211.61M-54.35%-139.63M-330.93%-64.1M-179.71%-231.81M-178.05%-141.11M
Research and development expenses 18.02%-637.99M15.92%-461.67M-4.45%-338.37M4.70%-149.77M11.43%-778.26M16.27%-549.07M41.23%-323.97M41.75%-157.16M-105.08%-878.72M-271.09%-655.77M
Profit from asset sales ------37.46K--------------------------------
Revaluation surplus -----379.50%-15.37M----56.12%7.17M-----82.25%5.5M----670.43%4.59M----209.47%30.98M
-Changes in the fair value of other assets -----379.50%-15.37M----56.12%7.17M-----82.25%5.5M----670.43%4.59M----209.47%30.98M
Impairment and provision -71.43%-15.05M-50.46%-801.12M-338.13%-20.26M-108.88%-12.87M-381.20%-8.78M-11,281.90%-532.45M-6,148.65%-4.62M-76,937.50%-6.16M-366.50%-1.82M---4.68M
-Other impairment is provision -71.43%-15.05M-50.46%-801.12M-338.13%-20.26M-108.88%-12.87M-381.20%-8.78M-11,281.90%-532.45M-6,148.65%-4.62M-76,937.50%-6.16M-366.50%-1.82M---4.68M
Special items of operating profit -5.26%141.72M44.00%167.28M-19.13%61.58M31.82%51.03M16.99%149.58M204.12%116.16M78.83%76.15M499.30%38.72M4.19%127.85M13.35%38.2M
Operating profit -48.69%-2.04B-73.96%-1.5B-714.58%-1.34B-242.43%-186.54M-171.60%-1.37B-169.67%-859.78M-120.54%-164.8M391.65%130.97M576.88%1.91B751.39%1.23B
Financing income -46.75%120.64M-----36.10%88.49M----184.45%226.57M----235.72%138.49M----151.10%79.65M----
Financing cost -53.82%-64.34M-62.52%80.29M-92.87%-29.4M36.14%-5.81M23.21%-41.83M250.27%214.19M-125.86%-15.24M-131.68%-9.1M-98.09%-54.48M379.25%61.15M
Special items of earning before tax -----3,128.89%-40.7M-----729.32%-8.12M----74.07%-1.26M-----323.52%-979K-----703.60%-4.86M
Earning before tax -67.14%-1.98B-125.10%-1.46B-2,988.28%-1.28B-265.82%-200.47M-161.13%-1.18B-150.13%-646.85M-104.97%-41.56M867.49%120.9M588.30%1.94B833.63%1.29B
Tax -94.78%11.45M-99.26%1.16M-97.98%1.16M558.59%30.27M838.17%219.24M263.56%158.17M-42.57%57.6M---6.6M---29.7M--43.51M
After-tax profit from continuing operations -103.93%-1.97B-197.72%-1.45B-8,092.09%-1.28B-248.91%-170.2M-150.59%-964.76M-136.64%-488.68M-98.29%16.04M825.59%114.3M580.81%1.91B858.36%1.33B
Earning after tax -103.93%-1.97B-197.72%-1.45B-8,092.09%-1.28B-248.91%-170.2M-150.59%-964.76M-136.64%-488.68M-98.29%16.04M825.59%114.3M580.81%1.91B858.36%1.33B
Minority profit -776.08%-484.7M-3,192.65%-469.89M-11,683.23%-440.74M-330.63%-30.65M-657.48%-55.33M---14.27M--3.81M-334.55%-7.12M---7.3M----
Profit attributable to shareholders -63.04%-1.48B-107.63%-985.03M-6,975.54%-841.43M-214.94%-139.55M-147.51%-909.43M-135.57%-474.41M-98.69%12.24M960.23%121.41M582.65%1.91B858.36%1.33B
Basic earnings per share -63.32%-6.01-107.81%-3.99-6,920.00%-3.41-216.33%-0.57-147.55%-3.68-135.62%-1.92-98.68%0.05916.67%0.49550.00%7.74791.03%5.39
Diluted earnings per share -63.32%-6.01-107.81%-3.99-6,920.00%-3.41-216.33%-0.57-147.55%-3.68-135.62%-1.92-98.68%0.05916.67%0.49550.00%7.74791.03%5.39
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASCAS (2007)HKASCAS (2007)HKASCAS (2007)HKASCAS (2007)HKASCAS (2007)
Audit Opinions Unqualified Opinion------Unqualified Opinion------Unqualified Opinion--
Auditor Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership)------Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership)------Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg